Jan 25, 2021

Dave Dillon interviews Dave Nelson, Luis Prieto and Joel Clark on the topic of buying and selling employer stop-loss, the nuances of the product and opportunities for health actuaries to evaluate the true risk needs and opportunities available in the employer stop-loss marketplace.

Jan 11, 2021

Listen to Jackie Lee and Ned Pojskic discuss how insurers and PBMs have a unique and creative challenge to collaborate with the pharmaceutical industry to innovate new mechanisms for single-use, high-cost therapies. Actuaries need to consider how cell and gene therapies are becoming more a platform for the development...

Dec 28, 2020

Dave Dillon, FSA, MAAA, interviews Greg Fann, FSA, FCA, MAAA on his October 2020 Health Watch article “The ACA Underwriting Cycle”. This discussion covers the historical underwriting cycle, the state of ACA markets, the need for actuarial voices in the ACA discussion, and the potential disruptors of ACA...

Dec 14, 2020

Cell and gene therapies; the challenges the insurance industry faces in modeling ultra high cost, novel therapies.

Nov 30, 2020

Do you want to get through the rate approval process faster or improve your chances of obtaining rate approval? In this podcast, Dave Dillon and Kristi Bohn talk about professionalism issues and other topics that directly relate to state regulatory filings.